Armondo López-Guillermo (A López-Guillermo, Armando López-Guillermo, Armando Lopez-Guillermo)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Lipopolysaccharide Induced

Top Venues

Leukemia & lymphoma

British journal of haematology

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, Raul Cordoba, Monica Tani, Peter Langmuir, Erica Rappold, Teng Liu, Armondo López-Guillermo
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112). Leukemia & lymphoma 65 (7) (2024)
Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, Raul Cordoba, Monica Tani, Peter Langmuir, Erica Rappold, Teng Liu, Armondo López-Guillermo
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112). Leukemia & lymphoma (2024)
Beatriz Rey Búa, Carlos Grande, Jose Javier Sánchez Blanco, Pau Abrisqueta, Antonio Gutierrez, Ángel R Payer, Eva Giné, Izaskun Zeberio Etxetxipia, Maria José Terol, Fátima de la Cruz Vicente, Rafael Andreu, María José Ramírez, Adolfo de la Fuente, María Cruz Viguria, María Jesus Peñarrubia, Ana Jiménez-Ubieto, Santiago Montes Moreno, Armondo López-Guillermo, María Dolores Caballero, Alejandro Martin Martin Garcia-Sancho
Ibrutinib and R-GemOx in patients with relapsed or refractory diffuse large B-cell lymphoma of non-GCB type: Phase II clinical trial of the Spanish GELTAMO group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Beatriz Rey Búa, Carlos Grande, Jose Javier Sánchez Blanco, Pau Abrisqueta, Antonio Gutierrez, Ángel R Payer, Eva Giné, Izaskun Zeberio Etxetxipia, Maria José Terol, Fátima de la Cruz Vicente, Rafael Andreu, María José Ramírez, Adolfo de la Fuente, María Cruz Viguria, María Jesus Peñarrubia, Ana Jiménez-Ubieto, Santiago Montes Moreno, Armondo López-Guillermo, María Dolores Caballero, Alejandro Martin Martin Garcia-Sancho
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, Raul Cordoba, Monica Tani, Peter Langmuir, Erica Rappold, Teng Liu, Armondo López-Guillermo
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112). Leukemia & lymphoma 65 (7) (2024)
Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, Andrea Blázquez, Joan Cid, Miquel Lozano, Laura Magnano, Eva Giné, Juan G Correa, Pablo Mozas, Luis Gerardo Rodríguez-Lobato, Andrea Rivero, Mercedes Montoro-Lorite, Pilar Ayora, Sergio Navarro, Leticia Alserawan, E Azucena González-Navarro, Maria Castellà, María Sánchez-Castañón, Raquel Cabezón, Daniel Benítez-Ribas, Xavier Setoaín, Sonia Rodríguez, Helena Brillembourg, Sara Varea, Eulalia Olesti, Elena Guillén, Joaquín Sáez-Peñataro, Carlos Fernández de Larrea, Armondo López-Guillermo, Mariona Pascal, Álvaro Urbano-Ispizua, Manel Juan, Julio Delgado
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma. British journal of haematology (2023)
Alejandro Martin Martin Garcia-Sancho, M Baile, G Rodríguez, Ivan Dlouhy, Juan-Manuel Sancho, I Jarque, E González-Barca, A Salar, M Espeso, C Grande, Juan-Miguel Bergua, S Montes-Moreno, A Redondo, A Enjuanes, E Campo, Armondo López-Guillermo, D Caballero
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO. British journal of haematology (2023)
Ana Muntañola, María Teresa Villalobos, Sonia González-Villambrosia, María José Rodríguez-Salazar, Ana Jiménez-Ubieto, Gabriela Bastidas-Mora, Raul Cordoba, María Infante, María Jesús Vidal, Francisco Javier Díaz, Mónica Baile, Mariana Bastos-Oreiro, Carlos Panizo, Juan-Manuel Sancho, Belén Navarro, Tomás García, Lourdes Escoda, Pau Abrisqueta, María José Terol, Raquel de Campo, Pablo Mozas, Armondo López-Guillermo, Antonio Salar-Silvestre, Carlos Montalbán, null null
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study. British journal of haematology (2023)
Ana Muntañola, Pablo Mozas, Santiago Mercadal, Maria Huguet, Sabela Bobillo, Mariana Bastos-Oreiro, Ana Jiménez-Ubieto, Jordina Rovira, Andrea Rivero, Carles Tolosa, Luis Luizaga, Sonia González de Villambrosia, Silvana Novelli, Dolores Caballero, Antonio Salar, Sara Alonso-Álvarez, Laura Magnano, Norma C Gutiérrez, Juan-Manuel Sancho, Armondo López-Guillermo, null null
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome. British journal of haematology (2022)
Judith Trotman, Loretta J Nastoupil, Pierre Feugier, Jean Marc Schiano De Colella, Hervé Tilly, Maria Lia Palomba, Emmanuel Bachy, Christophe Fruchart, Edward N Libby, René-Olivier Casasnovas, Ian W Flinn, Corinne Haioun, Hervé Maisonneuve, Loic Ysebaert, Nancy L Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Steven Le Gouill, Nicolas Daguindau, Stéphanie Guidez, Gian Matteo Pica, Alejandro Martin Martin Garcia-Sancho, Armondo López-Guillermo, Jean-François Larouche, Kiyoshi Ando, Maria Gomes da Silva, Marc André, Ka Lung Wu, Laurie Helen Sehn, Koji Izutsu, Guillaume Cartron, Argyrios Gkasiamis, Russell Crowe, Luc Xerri, Nathan H Fowler, Gilles Andre Salles
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R 2 ) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Eva Giné, Fátima de la Cruz, Ana Jiménez Ubieto, Javier López Jiménez, Alejandro Martin Martin Garcia-Sancho, M José Terol, Eva González Barca, María Casanova, Adolfo de la Fuente, Ana Marin-Niebla, Ana Muntañola, Tomás José González-López, Marta Aymerich, Xavier Setoain, Montserrat Cortés-Romera, Amanda Rotger, Sonia Rodríguez, Alejandro Medina Herrera, Miriam Santero, Ferran Nadeu, Sílvia Beà, Elias Campo, Armondo López-Guillermo
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (11) (2022)
Pablo Mozas, Armondo López-Guillermo
Response to: The lymphocyte-to-monocyte ratio in follicular lymphoma. Leukemia & lymphoma 62 (10) (2021)
Armondo López-Guillermo, Miguel Ángel Canales, Ivan Dlouhy, Santiago Mercadal, Javier Briones, Alejandro Martín García-Sancho, Juan Manuel Sancho, José María M Moraleda, María José Terol, Antonio Salar, Luis Palomera, Santiago Gardella, Isidro Jarque, Secundino Ferrer, Joan Bargay, Andrés López, Carlos Panizo, Anna Muntañola, Carlos Montalbán, Eulogio Conde, Miguel T Hernández, Alfons Soler, José A García Marco, Guillermo Deben, Julián Marín, José Francisco Tomás, null null
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. Leukemia & lymphoma (2021)
Gabriela Bastidas-Mora, Sílvia Beà, Alba Navarro, Eva Gine, Dolors Costa, Julio Delgado, Tycho Baumann, Laura Magnano, Alfredo Rivas-Delgado, Neus Villamor, Dolors Colomer, Mònica López-Guerra, María Rozman, Olga Balagué, Daniel Martinez, Maria Joao Baptista, Lourdes Escoda, Miguel Alcoceba, Margarita Blanes, Fina Climent, Elias Campo, Andrew Wotherspoon, Armondo López-Guillermo, Estella Matutes
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation. British journal of haematology (2021)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Eva Giné, Julio Delgado, Neus Villamor, Elias Campo, Patricia Pérez-Galán, Laura Magnano, Armondo López-Guillermo
The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma. Leukemia & lymphoma (2021)
Ivan Dlouhy, Kennosuke Karube, Anna Enjuanes, Itziar Salaverria, Ferran Nadeu, Juan Enric Ramis-Zaldivar, Juan G Valero, Alfredo Rivas-Delgado, Laura Magnano, David Martin-García, Patricia Pérez-Galán, Guillem Clot, Jordina Rovira, Pedro Jares, Olga Balagué, Eva Giné, Pablo Mozas, Javier Briones, Juan-Manuel Sancho, Antonio Salar, Santiago Mercadal, Miguel Alcoceba, Alexandra Valera, Elías Campo, Armondo López-Guillermo
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. British journal of haematology (2021)
Pablo Mozas, Marc Sorigue, Alfredo Rivas-Delgado, Andrea Rivero, Juan Gonzalo Correa, Carlos Castillo, Ferran Nadeu, Alex Bataller, Eva Giné, Tycho Baumann, Julio Delgado, Neus Villamor, Elias Campo, Laura Magnano, Juan-Manuel Sancho, Armondo López-Guillermo
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients. European journal of haematology 106 (3) (2020)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Guillem Clot, Juan Gonzalo Correa, Carlos Castillo, Alex Bataller, Tycho Baumann, Eva Giné, Julio Delgado, Neus Villamor, Elias Campo, Patricia Pérez-Galán, Laura Magnano, Armondo López-Guillermo
A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma. Leukemia & lymphoma 62 (1) (2020)
Alfredo Rivas-Delgado, Ferran Nadeu, Anna Enjuanes, Sebastián Casanueva-Eliceiry, Pablo Mozas, Laura Magnano, Natalia Castrejon, Jordina Rovira, Ivan Dlouhy, Silvia Martín, Miguel Osuna, Sonia Rodríguez, Marc Simó, Magda Pinyol, Tycho Baumann, Sílvia Beà, Olga Balagué, Neus Villamor, Xavier Setoain, Elias Campo, Eva Giné, Armondo López-Guillermo
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Guillem Clot, Pedro Jares, Eva Giné, Alba Navarro, Cristina Royo, Magda Pinyol, David Martín-Garcia, Santiago Demajo, Blanca Espinet, Antonio Salar-Silvestre, Ana Ferrer, Ana Muntañola, Marta Aymerich, Hilka Rauert-Wunderlich, Elaine S Jaffe, Joseph M Connors, Randy D Gascoyne, Jan Delabie, Armondo López-Guillermo, German Ott, George W Wright, Louis M Staudt, Andreas Rosenwald, David W Scott, Lisa M Rimsza, Sílvia Beà, Elias Campo
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome. Blood 132 (4) (2018)